Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Critical Care Medicine|October 1, 1993
Preclinical review of anti-tumor necrosis factor monoclonal antibodiesM Bodmer, M A Fournel, L B HinshawBlood|October 15, 1990
Characterization of recombinant factor VIII and a recombinant factor VIII deletion mutant using a rabbit immunogenicity model systemP C Esmon, H S Kuo, M A FournelBiochemistry|July 8, 1980
Kinetics of activation of prekallikrein by prekallikrein activatorD L Tankersley, M A Fournel, D D SchroederTransfusion|November 1, 1981
Plasma protein fraction. Product improvement studiesP K Ng, M A Fournel, J L LundbladThe American Journal of Medicine|September 11, 1989
Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremiaT E Emerson, M A Fournel, T B Redens, et al.The American Journal of Medicine|June 24, 1988
Preclinical evaluation of alpha-1-proteinase inhibitor. Pharmacokinetics and safety studiesM A Fournel, J O Newgren, C M Betancourt, et al.Circulatory Shock|January 1, 1987
Protection against disseminated intravascular coagulation and death by antithrombin-III in the Escherichia coli endotoxemic ratT E Emerson, M A Fournel, W J Leach, et al.The Journal of Laboratory and Clinical Medicine|October 1, 1992
Monoclonal antibody to tumor necrosis factor--alpha prevents lethal endotoxin sepsis in adult rhesus monkeysV B Fiedler, I Loof, E Sander, et al.Blood|July 1, 1988
In vivo characterization of recombinant factor VIII in a canine model of hemophilia A (factor VIII deficiency)A R Giles, S Tinlin, H Hoogendoorn, et al.Circulatory Shock|October 11, 1992
Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon modelT E Emerson, D C Lindsey, G J Jesmok, et al.Pageof 2